142 related articles for article (PubMed ID: 2380504)
1. Effects of vitamin D3 metabolites on thyrotropin secretion from rat pituitary cells in culture.
Törnquist K; Forss L; Lamberg-Allardt C
J Endocrinol Invest; 1990 May; 13(5):391-5. PubMed ID: 2380504
[TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D3 enhances thyrotropin releasing hormone induced thyrotropin secretion in normal pituitary cells.
D'Emden MC; Wark JD
Endocrinology; 1987 Sep; 121(3):1192-4. PubMed ID: 3113918
[TBL] [Abstract][Full Text] [Related]
3. Effect of 1,25-dihydroxyvitamin D3 on TSH secretion from rat pituitary cells in culture.
Törnquist K; Lamberg-Allardt C
Acta Endocrinol (Copenh); 1987 Mar; 114(3):357-61. PubMed ID: 3564838
[TBL] [Abstract][Full Text] [Related]
4. Effects of tri-iodothyronine, cortisol and transcriptional inhibitors on vitamin D3-enhanced thyrotrophin secretion by rat pituitary cells in vitro.
d'Emden MC; Wark JD
J Endocrinol; 1989 Jun; 121(3):451-8. PubMed ID: 2502597
[TBL] [Abstract][Full Text] [Related]
5. Culture requirements for optimal expression of 1 alpha,25-dihydroxyvitamin D3-enhanced thyrotropin secretion.
d'Emden MC; Wark JD
In Vitro Cell Dev Biol; 1991 Mar; 27A(3 Pt 1):197-204. PubMed ID: 1903381
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D-enhanced thyrotrophin release from rat pituitary cells: effects of Ca2+, dihydropyridines and ionomycin.
d'Emden MC; Wark JD
J Endocrinol; 1989 Jun; 121(3):441-50. PubMed ID: 2474048
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitro.
Skjødt H; Gallagher JA; Beresford JN; Couch M; Poser JW; Russell RG
J Endocrinol; 1985 Jun; 105(3):391-6. PubMed ID: 3873510
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of some hydroxylated vitamin D metabolites on parathyrin secretion by dispersed rat parathyroid cells in vitro.
Gruson M; Demignon J; Del Pino Montes J; Miravet L
Steroids; 1982 Sep; 40(3):275-85. PubMed ID: 6985176
[TBL] [Abstract][Full Text] [Related]
9. Systemic effects of 1,25-dihydroxyvitamin D3 on the pituitary-hypothalamic axis in rats.
Törnquist K; Lamberg-Allardt C
Acta Endocrinol (Copenh); 1987 Jun; 115(2):225-8. PubMed ID: 3111137
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the 1,25-(OH)2D3-induced inhibition of bone nodule formation in long-term cultures of fetal rat calvaria cells.
Ishida H; Bellows CG; Aubin JE; Heersche JN
Endocrinology; 1993 Jan; 132(1):61-6. PubMed ID: 8419147
[TBL] [Abstract][Full Text] [Related]
11. Effects of 24,25(OH)2D3, 1,25(OH)2D3 and 25(OH)D3 on alkaline and tartrate-resistant acid phosphatase activities in fetal rat calvaria.
Municio MJ; Traba ML
J Physiol Biochem; 2004 Sep; 60(3):219-24. PubMed ID: 15700769
[TBL] [Abstract][Full Text] [Related]
12. Effect of 1,25(OH)2D3 on the TSH secretion from rat pituitary cells.
Törnquist K; Lamberg-Allardt C
Horm Metab Res; 1986 Jan; 18(1):69. PubMed ID: 3753950
[TBL] [Abstract][Full Text] [Related]
13. Maturation-dependent regulation of protein kinase C activity by vitamin D3 metabolites in chondrocyte cultures.
Sylvia VL; Schwartz Z; Schuman L; Morgan RT; Mackey S; Gomez R; Boyan BD
J Cell Physiol; 1993 Nov; 157(2):271-8. PubMed ID: 8227160
[TBL] [Abstract][Full Text] [Related]
14. A permissive role for extracellular Ca2+ in regulation of prolactin production by 1,25-dihydroxyvitamin D3 in GH3 pituitary cells.
Haug E; Bjøro T; Gautvik KM
J Steroid Biochem; 1987 Oct; 28(4):385-91. PubMed ID: 2889849
[TBL] [Abstract][Full Text] [Related]
15. Apparent nonnuclear regulation of intestinal phosphate transport: effects of 1,25-dihydroxyvitamin D3,24,25-dihydroxyvitamin D3, and 25-hydroxyvitamin D3.
Nemere I
Endocrinology; 1996 Jun; 137(6):2254-61. PubMed ID: 8641173
[TBL] [Abstract][Full Text] [Related]
16. Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium.
Itin PH; Pittelkow MR; Kumar R
Endocrinology; 1994 Nov; 135(5):1793-8. PubMed ID: 7956903
[TBL] [Abstract][Full Text] [Related]
17. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
Mortensen BM; Gautvik KM; Gordeladze JO
Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
[TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3-induced upregulation of the thyrotropin-releasing hormone receptor in clonal rat pituitary GH3 cells.
Atley LM; Lefroy N; Wark JD
J Endocrinol; 1995 Dec; 147(3):397-404. PubMed ID: 8543909
[TBL] [Abstract][Full Text] [Related]
19. Effect of 1,25-dihydroxyvitamin D3 on rat pituitary prolactin release.
Törnquist K
Acta Endocrinol (Copenh); 1987 Dec; 116(4):459-64. PubMed ID: 3425161
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
Magliola L; Anast CS; Forte LR
Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
